The hypothesis of an increased mortality following paclitaxel coated device use in peripheral vascular interventions (and the emerging era of meta-analysis based evidence)
Catheter Cardiovasc Interv
.
2020 Feb;95(2):329-331.
doi: 10.1002/ccd.28600.
Epub 2019 Nov 19.
Authors
Bernardo Cortese
1
,
Fernando Alfonso
2
,
Dario Pellegrini
3
4
,
Krishna R Sing
5
,
Juan F Granada
6
Affiliations
1
San Carlo Clinic, Milan, Italy.
2
Hospital Universitario de La Princesa, Madrid, Spain.
3
Universitá degli Studi Milano-Bicocca, Milan, Italy.
4
Radboud UMC, Nijmegen, Netherlands.
5
Prairie Heart Institute of Illinois at St. John's Hospital, Springfield, Illinois.
6
Cardiovascular Research Foundation, Columbia University Medical Center, New York, New York.
PMID:
31743534
DOI:
10.1002/ccd.28600
No abstract available
Publication types
Editorial
Comment
MeSH terms
Angioplasty, Balloon*
Femoral Artery
Humans
Leg
Paclitaxel*
Randomized Controlled Trials as Topic
Stents
Treatment Outcome
Substances
Paclitaxel